Drug Shortage Report for NAPROSYN

Last updated on 2023-05-26 History
Report ID 181466
Drug Identification Number 02162466
Brand name NAPROSYN
Common or Proper name Naproxen sustained release tablets
Company Name ATNAHS PHARMA UK LIMITED
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 750MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100s
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-01-19
Actual start date 2023-01-19
Estimated end date Unknown
Actual end date 2023-05-25
Shortage status Resolved
Updated date 2023-05-26
Company comments Batch released
Health Canada comments
Tier 3 Status No
Contact Address SOVEREIGN HOUSE, MILES GRAY ROAD
BASILDON, ESSEX
GREAT BRITAIN SS14 3FR
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-05-26 English Compare
v6 2023-05-25 French Compare
v5 2023-05-25 English Compare
v4 2023-05-25 English Compare
v3 2023-01-20 English Compare
v2 2023-01-18 French Compare
v1 2023-01-18 English Compare

Showing 1 to 7 of 7